Cart
sales@molnova.com
Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate
CAS No. 90685-26-0
Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate( —— )
Catalog No. M31577 CAS No. 90685-26-0
Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate is a natural product.
-
DescriptionMethyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate is a natural product.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number90685-26-0
-
Formula Weight610.6
-
Molecular FormulaC29H38O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Osteogenic Growth Pe...
Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
BCAT-IN-2
BCAT-IN-2 is an orally active and selective inhibitor of mitochondrial branched-chain aminotransferase (BCATm), inhibits BCATm and BCATc, and is used in obesity and dyslipidemia.
